BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30889542)

  • 21. Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells.
    Sudan S; Rupasinghe HP
    Anticancer Res; 2014 Apr; 34(4):1691-9. PubMed ID: 24692698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines.
    Qian JQ; Sun P; Pan ZY; Fang ZZ
    Int J Clin Exp Pathol; 2015; 8(9):11934-44. PubMed ID: 26617951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of Apoptosis and Cytotoxicity by Isothiocyanate Sulforaphene in Human Hepatocarcinoma HepG2 Cells.
    Kntayya SB; Ibrahim MD; Mohd Ain N; Iori R; Ioannides C; Abdull Razis AF
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29866995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
    Lee S; Lee M; Kim JB; Jo A; Cho EJ; Yu SJ; Lee JH; Yoon JH; Kim YJ
    Biochem Biophys Res Commun; 2016 May; 473(4):1247-1254. PubMed ID: 27091428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence.
    da Silva EFG; Lima KG; Krause GC; Haute GV; Pedrazza L; Catarina AV; Gassen RB; de Souza Basso B; Dias HB; Luft C; Garcia MCR; Costa BP; Antunes GL; Basso LA; Donadio MVF; Machado P; de Oliveira JR
    Invest New Drugs; 2020 Dec; 38(6):1653-1663. PubMed ID: 32367200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cells.
    Zhang L; Li Y; Qiao L; Zhao Y; Wei Y; Li Y
    Int J Oncol; 2015 Aug; 47(2):632-40. PubMed ID: 26035065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
    Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.
    Miyata M; Morishita A; Sakamoto T; Katsura A; Kato K; Nishioka T; Toyota Y; Fujita K; Maeda E; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Fujiwara S; Nishiyama N; Iwama H; Himoto T; Hirashima M; Masaki T
    Int J Oncol; 2015 Aug; 47(2):535-42. PubMed ID: 26060089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticancer activity of new cationic arylthiophenes against hepatocellular carcinoma.
    Al-Shun SA; El-Senduny FF; Ismail MA; El-Sayed WM; Badria FA; Youssef MM
    Life Sci; 2021 Mar; 269():119028. PubMed ID: 33444618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hexabromocyclododecane and polychlorinated biphenyls increase resistance of hepatocellular carcinoma cells to cisplatin through the phosphatidylinositol 3-kinase/protein kinase B pathway.
    An J; Wang X; Guo P; Zhong Y; Zhang X; Yu Z
    Toxicol Lett; 2014 Aug; 229(1):265-72. PubMed ID: 24960055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression.
    Hsu C; Lin LI; Cheng YC; Feng ZR; Shao YY; Cheng AL; Ou DL
    Clin Cancer Res; 2016 May; 22(10):2555-64. PubMed ID: 26603262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JA, a new type of polyunsaturated fatty acid isolated from Juglans mandshurica Maxim, limits the survival and induces apoptosis of heptocarcinoma cells.
    Gao XL; Lin H; Zhao W; Hou YQ; Bao YL; Song ZB; Sun LG; Tian SY; Liu B; Li YX
    Apoptosis; 2016 Mar; 21(3):340-50. PubMed ID: 26621097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.
    Huo S; Yu H; Li C; Zhang J; Liu T
    Int J Clin Exp Pathol; 2015; 8(12):15863-70. PubMed ID: 26884857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical roles of cellular glutathione homeostasis and jnk activation in andrographolide-mediated apoptotic cell death in human hepatoma cells.
    Ji L; Shen K; Jiang P; Morahan G; Wang Z
    Mol Carcinog; 2011 Aug; 50(8):580-91. PubMed ID: 21319226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SRJ09, a promising anticancer drug lead: Elucidation of mechanisms of antiproliferative and apoptogenic effects and assessment of in vivo antitumor efficacy.
    Wong CC; Lim SH; Sagineedu SR; Lajis NH; Stanslas J
    Pharmacol Res; 2016 May; 107():66-78. PubMed ID: 26940565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
    Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
    PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives.
    Dey SK; Bose D; Hazra A; Naskar S; Nandy A; Munda RN; Das S; Chatterjee N; Mondal NB; Banerjee S; Saha KD
    PLoS One; 2013; 8(3):e58055. PubMed ID: 23472133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells.
    Zhou Z; Lu X; Zhu P; Zhu W; Mu X; Qu R; Li M
    Biochem Biophys Res Commun; 2012 Apr; 420(2):336-42. PubMed ID: 22425983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
    You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K
    Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.